Combination Therapy for Overactive Bladder: Should We Define Refractoriness?

Eur Urol. 2019 Dec;76(6):780-781. doi: 10.1016/j.eururo.2019.09.003. Epub 2019 Sep 18.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Combined Modality Therapy
  • Drug Therapy, Combination
  • Humans
  • Muscarinic Antagonists
  • Urinary Bladder, Overactive*

Substances

  • Muscarinic Antagonists